Jpmorgan Chase & CO Nevro Corp Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Nevro Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 263,570 shares of NVRO stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

263,570

Previous 506,382 47.95%

Holding current value

$1.54 Million

Previous $1.88 Million 18.27%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$3.29 - $5.85 $798,851 - $1.42 Million	-242,812 Reduced 47.95%	263,570 $1.54 Million
Q4 2024 Feb 12, 2025	BUY	$3.59 - $5.78 $988,255 - $1.59 Million	275,280 Added 119.12%	506,382 $1.88 Million
Q3 2024 Dec 26, 2024	BUY	$4.71 - $10.1 $395,696 - $848,521	84,012 Added 57.12%	231,102 $1.29 Million
Q3 2024 Nov 08, 2024	BUY	$4.71 - $10.1 $395,696 - $848,521	84,012 Added 57.12%	231,102 $1.29 Million
Q2 2024 Dec 26, 2024	SELL	$7.96 - $13.59 $668,735 - $1.14 Million	-84,012 Reduced 36.35%	147,090 $1.24 Million
Q2 2024 Aug 12, 2024	BUY	$7.96 - $13.59 $199,167 - $340,035	25,021 Added 20.5%	147,090 $1.24 Million
Q1 2024 Dec 26, 2024	SELL	$13.56 - $20.78 $1.48 Million - $2.27 Million	-109,033 Reduced 47.18%	122,069 $1.76 Million
Q1 2024 May 10, 2024	BUY	$13.56 - $20.78 $643,964 - $986,842	47,490 Added 63.68%	122,069 $1.76 Million
Q4 2023 Dec 26, 2024	SELL	$14.18 - $22.31 $2.22 Million - $3.49 Million	-156,523 Reduced 67.73%	74,579 $1.6 Million
Q4 2023 Feb 12, 2024	SELL	$14.18 - $22.31 $617,212 - $971,087	-43,527 Reduced 36.85%	74,579 $1.6 Million
Q3 2023 Nov 14, 2023	SELL	$18.22 - $25.85 $196,757 - $279,154	-10,799 Reduced 8.38%	118,106 $2.27 Million
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $62,906 - $109,348	2,781 Added 2.2%	128,905 $3.28 Million
Q1 2023 May 18, 2023	BUY	$30.17 - $41.11 $1.33 Million - $1.81 Million	44,089 Added 53.74%	126,124 $4.56 Million
Q1 2023 May 11, 2023	SELL	$30.17 - $41.11 $42.3 Million - $57.7 Million	-1,403,436 Reduced 94.48%	82,035 $2.97 Million
Q4 2022 Feb 13, 2023	SELL	$36.43 - $49.4 $4.11 Million - $5.57 Million	-112,798 Reduced 7.06%	1,485,471 $58.8 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $8.99 Million - $11.7 Million	221,158 Added 16.06%	1,598,269 $74.5 Million
Q2 2022 Aug 11, 2022	BUY	$40.85 - $77.67 $446,286 - $848,544	10,925 Added 0.8%	1,377,111 $60.4 Million
Q1 2022 May 11, 2022	BUY	$59.95 - $92.06 $11.4 Million - $17.5 Million	189,887 Added 16.14%	1,366,186 $98.8 Million
Q4 2021 Feb 10, 2022	BUY	$81.07 - $121.29 $60,559 - $90,603	747 Added 0.06%	1,176,299 $95.4 Million
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $120 Million - $196 Million	1,175,552 New	1,175,552 $137 Million

Others Institutions Holding NVRO

# of Institutions

Shares Held

6.52M

Call Options Held

50K

Put Options Held

150K

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $207M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Nevro Corp Transaction History